1 Ocak 2011 Dergi makalesi Açık Erişim

Alicikus, Zumre A.; Yamada, Yoshiya; Zhang, Zhigang; Pei, Xin; Hunt, Margie; Kollmeier, Marisa; Cox, Brett; Zelefsky, Michael J.

JSON

{
  "conceptrecid": "21196", 
  "created": "2021-03-15T10:45:22.119163+00:00", 
  "doi": "10.1002/cncr.25467", 
  "files": [
    {
      "bucket": "d9857da0-d2b8-4659-98f8-da98b8e9b8b6", 
      "checksum": "md5:bac020104bed1455bb93cf062d68c774", 
      "key": "bib-9ea6b9ca-29a9-461f-85ec-318a8601fdbb.txt", 
      "links": {
        "self": "https://aperta.ulakbim.gov.tr/api/files/d9857da0-d2b8-4659-98f8-da98b8e9b8b6/bib-9ea6b9ca-29a9-461f-85ec-318a8601fdbb.txt"
      }, 
      "size": 224, 
      "type": "txt"
    }
  ], 
  "id": 21197, 
  "links": {
    "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.1002/cncr.25467.svg", 
    "bucket": "https://aperta.ulakbim.gov.tr/api/files/d9857da0-d2b8-4659-98f8-da98b8e9b8b6", 
    "doi": "https://doi.org/10.1002/cncr.25467", 
    "html": "https://aperta.ulakbim.gov.tr/record/21197", 
    "latest": "https://aperta.ulakbim.gov.tr/api/records/21197", 
    "latest_html": "https://aperta.ulakbim.gov.tr/record/21197"
  }, 
  "metadata": {
    "access_right": "open", 
    "access_right_category": "success", 
    "communities": [
      {
        "id": "tubitak-destekli-proje-yayinlari"
      }
    ], 
    "creators": [
      {
        "affiliation": "Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA", 
        "name": "Alicikus, Zumre A."
      }, 
      {
        "affiliation": "Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA", 
        "name": "Yamada, Yoshiya"
      }, 
      {
        "affiliation": "Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA", 
        "name": "Zhang, Zhigang"
      }, 
      {
        "affiliation": "Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA", 
        "name": "Pei, Xin"
      }, 
      {
        "affiliation": "Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA", 
        "name": "Hunt, Margie"
      }, 
      {
        "affiliation": "Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA", 
        "name": "Kollmeier, Marisa"
      }, 
      {
        "affiliation": "Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA", 
        "name": "Cox, Brett"
      }, 
      {
        "affiliation": "Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA", 
        "name": "Zelefsky, Michael J."
      }
    ], 
    "description": "BACKGROUND. The authors investigated long-term tumor control and toxicity outcomes after high-dose, intensity-modulated radiation therapy (IMRT) in patients who had clinically localized prostate cancer. METHODS. Between April 1996 and January 1998, 170 patients received 81 gray (Gy) using a 5-field IMRT technique. Patients were classified according to the National Comprehensive Cancer Network-defined risk groups. Toxicity data were scored according to the Common Terminology Criteria for Adverse Events Version 3.0. Freedom from biochemical relapse, distant metastases, and cause-specific survival outcomes were calculated. The median follow-up was 99 months. RESULTS. The 10-year actuarial prostate-specific antigen relapse-free survival rates were 81% for the low-risk group, 78% for the intermediate-risk group, and 62% for the high-risk group; the 10-year distant metastases-free rates were 100%, 94%, and 90%, respectively; and the 10-year cause-specific mortality rates were 0%, 3%, and 14%, respectively. The 10-year likelihood of developing grade 2 and 3 late genitourinary toxicity was 11% and 5%, respectively; and the 10-year likelihood of developing grade 2 and 3 late gastrointestinal toxicity was 2% and 1%, respectively. No grade 4 toxicities were observed. CONCLUSIONS. To the authors' knowledge, this report represents the longest followed cohort of patients who received high-dose radiation levels of 81 Gy using IMRT for localized prostate cancer. The findings indicated that high-dose IMRT is well tolerated and is associated with excellent long-term tumor-control outcomes in patients with localized prostate cancer Cancer 2011; 117: 1429-37. (C) 2010 American Cancer Society.", 
    "doi": "10.1002/cncr.25467", 
    "has_grant": false, 
    "journal": {
      "issue": "7", 
      "pages": "1429-1437", 
      "title": "CANCER", 
      "volume": "117"
    }, 
    "license": {
      "id": "cc-by"
    }, 
    "publication_date": "2011-01-01", 
    "relations": {
      "version": [
        {
          "count": 1, 
          "index": 0, 
          "is_last": true, 
          "last_child": {
            "pid_type": "recid", 
            "pid_value": "21197"
          }, 
          "parent": {
            "pid_type": "recid", 
            "pid_value": "21196"
          }
        }
      ]
    }, 
    "resource_type": {
      "subtype": "article", 
      "title": "Dergi makalesi", 
      "type": "publication"
    }, 
    "title": "Ten-Year Outcomes of High-Dose, Intensity-Modulated Radiotherapy for Localized Prostate Cancer"
  }, 
  "owners": [
    1
  ], 
  "revision": 1, 
  "stats": {
    "downloads": 4.0, 
    "unique_downloads": 4.0, 
    "unique_views": 11.0, 
    "version_downloads": 4.0, 
    "version_unique_downloads": 4.0, 
    "version_unique_views": 11.0, 
    "version_views": 11.0, 
    "version_volume": 896.0, 
    "views": 11.0, 
    "volume": 896.0
  }, 
  "updated": "2021-03-15T10:45:22.164132+00:00"
}